PRODUCT

°í°´¸¸Á·À» À§ÇØ Áö¼ÓÀûÀ¸·Î °í¹ÎÇϰí Çõ½ÅÇÏ¿© ÃÖ°íÀÇ Ç°ÁúÀ» Á¦°øÇÕ´Ï´Ù.

R&D reagents

Product > R&D reagents
Atropine sulfate monohydrate, 98%
CAS No 67835-5g
Á¦Ç°¹øÈ£ AK Sci.(USA)
Á¦Á¶»ç ¼öÀÔ»ê
Àç°í 1 EA
±Ý¾× 39,000¿ø
Æ÷Àå´ÜÀ§
Æ÷Àå´ÜÀ§



a-(Hydroxymethyl)benzeneacetic acid (3-endo)-8- methyl-8-azabicyclo[3.2.1]oct-3-yl ester sulfate monohydrate





¡Ø È­Çиí : Atropine sulfate monohydrate, 98%

 

¡Ø µî±Þ : APIs and Bioactives > Alkaloids, AChR Antagonists

 

¡Ø ÆÇ¸Å Æ÷Àå´ÜÀ§ : 5g , 25g , 100g

 

¡Ø È­ÇÐ½Ä : C34H46N2O6.H2SO4.H2O

 

¡Ø CAS # : [5908-99-6]

 

 

 

IDENTITY
CAS Registry #:

 

[5908-99-6]

MDL Number: MFCD00074815
MF: C34H46N2O6.H2SO4.H2O
MW: 694.8326
EINECS: 200-104-8
BRN: 6109275
SPECIFICATIONS & PROPERTIES
Purity: 98%
Physical Form: White crystalline powder
Melting Point: 190-193¡ÆC
Optical Rotation: -0.6 ¡Æ(per USP 25¡ÆC)
Long-Term Storage: Store long-term at 2-8¡ÆC
Shipping: Regulated for Shipping
UN #: 1544
Hazard Class: 6.1
Packing Group: II

BIOLOGICAL INFO
Application(s): Competitive muscarinic acetylcholine receptor antagonis
Form: Sulfate salt monohydrate

REVIEW

Atropine binds to and inhibit muscarinic acetylcholine receptors, producing a wide range of anticholinergic effects.

REFERENCES
[1] Field JM, Hazinski MF, Sayre MR, et al. (November 2010). Part 1: executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 122 (18 Suppl 3): S640-56. doi:10.1161/CIRCULATIONAHA.110.970889. PMID 20956217.
[2] Bryan E, Bledsoe; Robert S. Porter, Richard A. Cherry (2004). Ch. 3. Intermediate Emergency Care. Upper Saddle River, NJ: Pearson Prentice Hill. p. 260. ISBN 0-13-113607-0.
[3] Georgievski Z, Koklanis K, Leone J. Fixation behavior in the treatment of amblyopia using atropine. Clinical and Experimental Ophthalmology 2008; 36 (Suppl 2): A764-A765.

Risk Description(s)
R26/28: Very toxic by inhalation and if swallowed
R36/37/38: Irritating to eyes, respiratory system and skin
R43: May cause sensitization by skin contact.

Safety Description(s)
S1: Keep locked up.
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36/37/39: Wear suitable protective clothing, gloves and eye/face protection.
S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).